4Kscore testProstate Cancer Prevention Trial-Risk CalculatorEuropean Research Screening Prostate Cancer-Risk Calculator 4Clinical utility curvesPredictive modelsProstate biopsyValidationClinical utilityTo prevent the overdiagnosis and overtreatment of prostate cancer (PC), therapeutic strategies have been established...
Calibration analyses demonstrated that the MUSIC model more accurately predicted observed outcomes, whereas the PCPT risk calculator substantively overestimated the likelihood of finding no cancer while underestimating the risk of high-grade cancer in this population. Conclusion The PCPT risk calculator may ...
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy. Prostate Cancer Prostatic Dis. 2017;20(2):179-185.PubMedGoogle ScholarCrossref 14. Park JY, Yoon S, Park MS, et al. Development and external validation of the ...
found that compared to mpMRI and clinical presentation, [68Ga]Ga-PSMA-11 PET/CT demonstrated higher diagnostic efficacy for PI-RADS 3 score patients and had an advantage over the european randomized study of screening for prostate cancer risk calculator 3 (ERSPC-RC3) and prostate cancer ...
Prostate cancer is a heterogeneous cancer with widely varying levels of morbidity and mortality. Approaches to prostate cancer screening, diagnosis, surveillance, treatment and management differ around the world. To identify the highest priority research
BACKGROUND: To adapt the well-performing European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculator to the Chinese setting and perf... Chiu,K P.,Roobol,... 被引量: 0发表: 0年 Correction: Development and External Validation of the Korean Prostate Cancer Risk Calculator...
Prostate Cancer Prevention Trial Risk Calculator 2.0 (PCPT-RC). The overall reduction in biopsies was reported to range between 30 and 58% depending on different thresholds, with only 1.3–4.7% cases of late diagnosis. When using a ≥ 6% probability of having a Gleason score ≥ 7 ...
Prostate Cancer Prevention Trial Risk Calculator 2.0 (PCPT-RC). The overall reduction in biopsies was reported to range between 30 and 58% depending on different thresholds, with only 1.3–4.7% cases of late diagnosis. When using a ≥ 6% probability of having a Gleason score ≥ 7 ...
Cancer Epidemiol Biomarkers Prevention, 19 (8) (2010), pp. 1893-1907 View in ScopusGoogle Scholar [13] D.K. Yoon, J.Y. Park, S. Yoon, M.S. Park, D.G. Moon, J.G. Lee, et al. Can the prostate risk calculator based on Western population be applied to Asian population? Prostate...
Recently, another study has confirmed that the European Randomized Study of Screening for Prostate Cancer risk calculator 3/4 (ERSPC-RC3/4) is performing well regarding the probability of csPCa [56]. Still, none of these models have been used to investigate whether covariates including PI-RADS ...